Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 1,819 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Depression, Eating Disorders, Body Image
Interventions: Project Body Neutrality SSI, Supportive Therapy SSI; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pediatric Sepsis
Interventions: For group Peds Sep A: Standard nutrition will be given, For Group Peds SepB: Low leucine, isoleucine formula, For Group Peds Sep C: Medium chain triglyceride oil enriched formula., For Group Peds Sep D: Low carbohydrate ketogenic formula; Dietary Supplement
Lead sponsor: University of Pittsburgh; Other
Eligibility: 44 Weeks to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obesity
Interventions: Intervention; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 9 Years to 100 Years
Enrollment: 890 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Interventions: BI 1839100, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 18
States / cities: Birmingham, Alabama • Lakewood, Colorado • Kissimmee, Florida + 14 more

Conditions: COMT Gene Polymorphism
Interventions: delta 9 tetrahydrocannabinol; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Stroke, Spinal Cord Injuries
Interventions: Behavioral Interaction Conditions, Haptic Impedance Level, Skill Level of Partner, Robot Controller Showcase; Behavioral · Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 80 Years
Enrollment: 764 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Restless Legs Syndrome
Interventions: MMF07 Foot Massager, Heat Therapy; Device
Lead sponsor: Ariane Park; Other
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Retinitis Pigmentosa, Leber Congenital Amaurosis
Interventions: OCU400 Low Dose, OCU400 Med Dose, OCU400 High Dose, OCU400 Second Eye Dosing; Drug
Lead sponsor: Ocugen; Industry
Eligibility: 6 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Phoenix, Arizona • La Jolla, California • Miami, Florida + 4 more

Conditions: Colorectal Cancer Screening
Interventions: Community Health Advisor, Usual care; Behavioral
Lead sponsor: Florida A&M University; Other
Eligibility: 45 Years to 64 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Bronchiectasis
Interventions: BI 1291583, Placebo matching BI 1291583; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 268 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 11
States / cities: Newport Beach, California • Sacramento, California • Gainesville, Florida + 8 more

Conditions: Pandemic Influenza
Interventions: A/H5N1, Placebo; Biological
Lead sponsor: Intercell USA, Inc.; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 501 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 5
States / cities: Vallejo, California • Miami, Florida • Kansas City, Kansas + 2 more

Conditions: Middle-ear Function
Interventions: varied middle-ear pressure, varied middle-ear gas composition, varied ear-canal pressure; Other · Drug
Lead sponsor: Cuneyt M. Alper; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Safe Sex
Interventions: Media Aware-Sexual Health; Behavioral
Lead sponsor: Innovation Research & Training; Other
Eligibility: 10 Years to 15 Years
Enrollment: 1,017 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetes Mellitus, Cardiovascular Disease
Interventions: Low support, Medium support, High support, Comparison; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 75 Years
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Head and Neck Cancer, Carotid Artery Stenosis, Cardiovascular Complication
Interventions: Carotid ultrasound, Blood draw, Survey; Procedure · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Partial Thickness Supraspinatus Tendon Tear, Full Thickness Supraspinatus Tendon Tear
Interventions: Bioinductive implant, Surgical repair; Device
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 15
States / cities: Van Nuys, California • Denver, Colorado • Fort Lauderdale, Florida + 12 more

Conditions: Muscle Protein Synthetic Response to Protein, Muscle Protein Synthesis, Muscle Health, Protein Metabolism, Recreational Activities, Isotope Labeling
Interventions: Resistance Exercise, Potato and Beef, Bread and Beef, Beef; Behavioral · Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 19 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Posttraumatic Stress Disorder
Interventions: Low dose MDMA-assisted therapy, Medium dose MDMA-assisted therapy, Full dose MDMA-assisted therapy, Therapy; Drug · Behavioral
Lead sponsor: Resilient Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Multiple Myeloma, Refractory, Multiple Myeloma in Relapse, Multiple Myeloma
Interventions: TEG002; Biological
Lead sponsor: Gadeta B.V.; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: placebo, orelabrutinib; Other · Drug
Lead sponsor: Beijing InnoCare Pharma Tech Co., Ltd.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: Ormond Beach, Florida • Tampa, Florida • Northbrook, Illinois + 2 more

Conditions: Obesity, Overweight
Interventions: Maridebart cafraglutide, Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 3,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 71
States / cities: Anniston, Alabama • Daphne, Alabama • Mobile, Alabama + 57 more

Conditions: Cancer, Hematologic Disorder, Rheumatologic Disorder, Infertility
Interventions: Ovarian Cryopreservation; Procedure
Lead sponsor: Vlad Radulescu; Other
Eligibility: 12 Years to 41 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 2
States / cities: Lexington, Kentucky • Louisville, Kentucky

Conditions: Sickle Cell Disease, Pain Management
Interventions: Hypnosis, Control; Other
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Infertility
Interventions: Comprehensive Chromosome Screening; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Basking Ridge, New Jersey

Search by objective public record fields.

Randomized Controlled Trial of Project Body Neutrality

Personalized Metabolic Nutrition Sepsis Study

B'More Healthy; Communities for Kids (BHCK)

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Pharmacogenetics of Cannabinoid Response

Human-like Robotic Controllers for Enhanced Motor Learning

A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

Test Up Now Education Program

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

A/H5N1 Dose Ranging Study With Adjuvant Patch

Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3

Evaluation of a Middle School Comprehensive Sexual Health Media Literacy Education Program

SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET

Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy

Post-Market Evaluation of the Rotation Medical Rotator Cuff System

Diet Synergy in Muscle Protein Synthesis

Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder

A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients

A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment

Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease

Sequential vs. Monophasic Media Impact Trial (SuMMIT)